![Paul Marinelli](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Paul Marinelli
Direttore/Membro del Consiglio presso
Neotx Holdings Ltd.
Patrimonio netto: 272 750 $ in data 31/08/2026
Profilo
Paul T.
Marinelli is currently Director at Neotx Holdings Ltd. since 2020 and Director at Paramount Skydance Corp.
starting in 2025.
Formerly, Mr. Marinelli was Director-Corporate Development Group at Cadence Design Systems, Inc. in 2004, Independent Director at LeapFrog Enterprises, Inc. from 2011 to 2012, Director at Skydance Media LLC, Director at Autonomous Medical Devices, Inc., Director at Imagene AI Ltd., and Vice President at Lawrence Investments LLC from 2004 to 2015.
Education includes an MBA from Cornell University and an undergraduate degree from the University of California, Berkeley.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
0% | 21/07/2026 | 25.000 ( 0% ) | 272 750 $ | 31/08/2026 |
Posizioni attive di Paul Marinelli
| Società | Posizione | Inizio |
|---|---|---|
Neotx Holdings Ltd.
 Neotx Holdings Ltd. Pharmaceuticals: MajorHealth Technology Develops oncology drugs | Direttore/Membro del Consiglio | 20/02/2020 |
Precedenti posizioni note di Paul Marinelli
| Società | Posizione | Fine |
|---|---|---|
Lawrence Investments LLC
 Lawrence Investments LLC Real Estate Investment TrustsFinance Offers properties for sale via this unique venue | Corporate Officer/Principal | 01/01/2015 |
| CADENCE DESIGN SYSTEMS, INC. | Corporate Officer/Principal | 01/05/2004 |
Autonomous Medical Devices, Inc.
 Autonomous Medical Devices, Inc. Aerospace & DefenseElectronic Technology Develops micro biosensor, computer chips and diagnostic devices | Direttore/Membro del Consiglio | - |
Imagene AI Ltd.
 Imagene AI Ltd. Information Technology ServicesTechnology Services Operates as AI-based molecular testing for cancer, leveraging the patient's histological data for personalized therapy | Direttore/Membro del Consiglio | - |
Skydance Media LLC
 Skydance Media LLC Movies/EntertainmentConsumer Services Produces films and TV content | Direttore/Membro del Consiglio | - |
Formazione di Paul Marinelli
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
68
Relazioni di 1° grado
9
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 9 |
|---|---|
Cadence Design Systems, Inc.
 Cadence Design Systems, Inc. Packaged SoftwareTechnology Services Provides software services for semiconductor and electronics systems industries | Technology Services |
LeapFrog Enterprises, Inc.
 LeapFrog Enterprises, Inc. Recreational ProductsConsumer Durables Designs, develops and markets innovative technology-based learning platforms and related proprietary content for children | Consumer Durables |
Lawrence Investments LLC
Lawrence Investments LLC Real Estate Investment TrustsFinance Offers properties for sale via this unique venue | Finance |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Skydance Media LLC
Skydance Media LLC Movies/EntertainmentConsumer Services Produces films and TV content | Consumer Services |
Autonomous Medical Devices, Inc.
Autonomous Medical Devices, Inc. Aerospace & DefenseElectronic Technology Develops micro biosensor, computer chips and diagnostic devices | Electronic Technology |
Neotx Holdings Ltd.
Neotx Holdings Ltd. Pharmaceuticals: MajorHealth Technology Develops oncology drugs | Health Technology |
Imagene AI Ltd.
Imagene AI Ltd. Information Technology ServicesTechnology Services Operates as AI-based molecular testing for cancer, leveraging the patient's histological data for personalized therapy | Technology Services |
